Homegrown COVID-19 pill gets regulatory approval
Share - WeChat

China's top drug regulator said on Monday it has granted conditional approval for a homegrown oral pill to be used to treat COVID-19.
Azvudine, developed by Genuine Biotech Co Ltd based in Henan province, was first approved to treat HIV/AIDS patients on July 20 last year, according to the National Medical Products Administration.
The approval clears the way for the pill to be used for adults with moderate COVID-19 symptoms, the administration said in a notice released on its official website.
- China completes construction of world's first wind-powered underwater data center
- Chinese telescope for advanced solar research now operational
- World's fastest high-speed train blazes to 453 km/h in pre-service trials
- Scientists discover rare meteorite relics in Chang'e 6 lunar samples
- Journey of a Xinjiang textile worker
- China's Harbin enters heating season